SCHEMBL6163693

SCHEMBL6163693

CC1(C)CCc2c(c(Cc3ccccc3)nn2-c2ccc(Cl)nn2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CDK2 P24941 2/20 0.39
CCNA2 P20248 1/20 0.39
ALDH1A1 P00352 4/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
KDM4E B2RXH2 1/20 0.34
VEGFA P15692 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
HPGD P15428 2/20 0.32
LMNA P02545 2/20 0.32
ALPL P05186 1/20 0.32
CYP3A4 P08684 1/20 0.32
CCNB2 O95067 1/20 0.31
CCNE2 O96020 1/20 0.31
CDK1 P06493 1/20 0.31
CDK4 P11802 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164821 0.85 CYP1A2 (0.43) RAB9ASMN1; SMN2CDK2CCNA2ALDH1A1
SCHEMBL6167233 0.84 CDK2 (0.39) RAB9ASMN1; SMN2CDK2CCNA2ALDH1A1
SCHEMBL6167555 0.79 CCNA2 (0.39) RAB9ASMN1; SMN2CDK2CCNA2
SCHEMBL6163516 0.76 CCNA2 (0.41) RAB9ASMN1; SMN2CDK2CCNA2ALDH1A1
SCHEMBL6164846 0.75 CCNA2 (0.38) RAB9ASMN1; SMN2CDK2CCNA2ALDH1A1
SCHEMBL6167319 0.74 RAB9A (0.38) RAB9ASMN1; SMN2CDK2CCNA2ALDH1A1
SCHEMBL6165092 0.73 CCNA2 (0.38) RAB9ASMN1; SMN2CDK2CCNA2ALDH1A1
SCHEMBL6167448 0.69 CYP1A2 (0.39) RAB9ASMN1; SMN2CDK2CCNA2ALDH1A1
SCHEMBL6167058 0.68 KDM4E (0.41) RAB9ASMN1; SMN2CDK2CCNA2ALDH1A1
SCHEMBL6166839 0.65 ALDH1A1 (0.50) RAB9ASMN1; SMN2CDK2CCNA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed